US · Healthcare · Medical Instruments & Supplies
EPS came in at 0.18 against a street estimate of 0.05 — a beat of 260.0%.
Analysts rate STAAR Surgical Company a buy (4 buy, 6 hold, 1 sell out of 11) with an average price target of $28.00.
| Fund | Stake |
|---|---|
| BROADWOOD CAPITAL Inc | 32.16% |
| BlackRock Inc | 13.42% |
| Madison Avenue Partners, LP | 8.33% |
| Yunqi Capital Ltd | 6.50% |
| Point72 Asset Management, L.P. | 4.86% |
| The Goldman Sachs Group Inc | 4.29% |
| Vanguard Portfolio Management, LLC | 3.95% |
| State Street Corp | 3.53% |
| Document | Date |
|---|---|
| Board / officer change · Q3 FY2027 STAAR SURGICAL COMPANY - 8-K SUMMARY BUSINESS & SEGMENT HIGHLIGHTS • STAAR Surgical Company appointed David Bailey as Chief Commercial Officer, effe | 2026-09-10 |
| Quarterly report · Q2 FY2027 STAAR SURGICAL COMPANY – 10-Q SUMMARY Quarter Ended July 3, 2026 --- HEADLINE NUMBERS • Net sales (6 months): $187,057 thousand vs. $86,909 thousan | 2026-08-12 |
| Results announced · Q3 FY2027 STAAR SURGICAL Q2 2026 RESULTS SUMMARY HEADLINE NUMBERS • Net sales: $93.5 million, up 111% year-over-year (Q2 2025: $44.3 million) • Net income: $8 | 2026-08-12 |
| Board / officer change · Q3 FY2027 STAAR SURGICAL COMPANY – 8-K SUMMARY HEADLINE NUMBERS • Warren Foust appointed President and CEO effective August 4, 2026, and added to Board of Dir | 2026-08-06 |
| Board / officer change · Q2 FY2027 STAAR SURGICAL COMPANY – 8-K SUMMARY HEADLINE NUMBERS • Annual shareholder meeting held June 18, 2026 • 49,788,295 shares outstanding as of April 20 | 2026-06-22 |
| Board / officer change · Q2 FY2027 STAAR SURGICAL COMPANY (STAA) – 8-K SUMMARY HEADLINE NUMBERS • Deborah Andrews (Interim Co-CEO and CFO) base salary increased from $512,000 to $575, | 2026-06-09 |
| Quarterly report · Q1 FY2027 STAAR SURGICAL COMPANY – Q1 2026 10-Q SUMMARY HEADLINE NUMBERS • Net sales Q1 2026: $93.5 million vs. $42.6 million Q1 2025 (+119% year-over-year) • | 2026-05-13 |
| Proxy statement · Q2 FY2027 STAAR SURGICAL COMPANY – 2026 PROXY SUMMARY WHAT SHAREHOLDERS ARE VOTING ON • Proposal 1 – Elect Seven Directors: Neal C. Bradsher, Arthur C. Butche | 2026-05-04 |
Readable in the app.
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for STAAR Surgical Company — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-19.